These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7831370)

  • 21. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal interleukin-1 expression during endotoxemia and gram-negative septicemia in conscious rats.
    Laszik Z; Nadasdy T; Johnson LD; Lerner MR; Brackett D; Silva FG
    Circ Shock; 1994 Jul; 43(3):115-21. PubMed ID: 7850931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factors: developments during the last decade.
    Aggarwal BB; Natarajan K
    Eur Cytokine Netw; 1996; 7(2):93-124. PubMed ID: 8688493
    [No Abstract]   [Full Text] [Related]  

  • 24. How do tumor necrosis factor receptors work?
    Bazzoni F; Beutler B
    J Inflamm; 1995; 45(4):221-38. PubMed ID: 8867667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor necrosis factor and lymphotoxin: molecular genetics, regulation and physiological role].
    Nedospasov SA
    Genetika; 2003 Feb; 39(2):207-14. PubMed ID: 12669416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of peptidoglycan-polysaccharide and lipopolysaccharide stimulation of Kupffer cells to produce tumor necrosis factor and interleukin-1.
    Lichtman SN; Wang J; Schwab JH; Lemasters JJ
    Hepatology; 1994 Apr; 19(4):1013-22. PubMed ID: 8138241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biochemistry and pharmacology of TNF alpha and beta, 21 April 1995, New York.
    Carty TJ; Gilman SC
    Inflamm Res; 1995 Nov; 44(11):455-7. PubMed ID: 8597876
    [No Abstract]   [Full Text] [Related]  

  • 28. The protective role of interleukin-10 in endotoxin shock.
    Marchant A; Bruyns C; Vandenabeele P; Abramowicz D; Gérard C; Delvaux A; Ghezzi P; Velu T; Goldman M
    Prog Clin Biol Res; 1994; 388():417-23. PubMed ID: 7831374
    [No Abstract]   [Full Text] [Related]  

  • 29. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
    Hazinski MF; Iberti TJ; MacIntyre NR; Parker MM; Tribett D; Prion S; Chmel H
    Am J Crit Care; 1993 May; 2(3):224-35; quiz 236-7. PubMed ID: 8364674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermia induces IL-1 alpha but does not decrease release of IL-1 alpha or TNF-alpha after endotoxin.
    Blake D; Bessey P; Karl I; Nunnally I; Hotchkiss R
    Lymphokine Cytokine Res; 1994 Oct; 13(5):271-5. PubMed ID: 7858059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circadian time structure of septic shock: timing is everything.
    Hrushesky WJ; Wood PA
    J Infect Dis; 1997 May; 175(5):1283-4. PubMed ID: 9129107
    [No Abstract]   [Full Text] [Related]  

  • 32. TNF in the inflammatory response.
    Männel DN; Echtenacher B
    Chem Immunol; 2000; 74():141-61. PubMed ID: 10608086
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of tumor necrosis factor-alpha in acute endotoxin-induced hepatotoxicity in ethanol-fed rats.
    Hansen J; Cherwitz DL; Allen JI
    Hepatology; 1994 Aug; 20(2):461-74. PubMed ID: 8045508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent effects of tumor necrosis factor-alpha and lymphotoxin-alpha on lethal endotoxemia and infection with live Salmonella typhimurium in mice.
    Dharmana E; Keuter M; Netea MG; Verschueren IC; Kullberg BJ
    Eur Cytokine Netw; 2002; 13(1):104-9. PubMed ID: 11956028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapies for sepsis. Emerging therapies for sepsis and septic shock.
    Abraham E
    West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195
    [No Abstract]   [Full Text] [Related]  

  • 38. Systemic and pulmonary reactions in swine with endotoxemia and gram-negative bacteremia.
    Olson NC; Kruse-Elliott KT; Dodam JR
    J Am Vet Med Assoc; 1992 Jun; 200(12):1870-84. PubMed ID: 1639692
    [No Abstract]   [Full Text] [Related]  

  • 39. [The evaluation of tumor necrosis factor-alpha concentration in body fluids in local and systemic endotoxin exposure].
    Kretzschmar C
    Zentralbl Veterinarmed B; 1996 Nov; 43(9):525-38. PubMed ID: 9045542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor necrosis factor. From theory to practice].
    Boudes P; Guillevin L
    Ann Med Interne (Paris); 1989; 140(8):715-20. PubMed ID: 2698074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.